Document is current
Any future updates will be listed below
-
Authors
Tian, Zhuang
Li, Xiaoyan
Li, Liwen
Zhang, Qing
Wang, Jian’an
Shi, Yunqi
Peng, Daoquan
Yang, Ping
Ma, Wei
Wang, Fang
Jin, Wei
Cheng, Xiang
Chen, Yu-Mao
Zhong, Yue
Barrett, Yu Chen
Zheng, Jing
Zhang, Shuyang https://orcid.org/0000-0002-1532-0029
-
Funding
Funding for this research was provided by:
Bristol Myers Squibb
Shanghai LianBio Development Co., Ltd
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 31 March 2025
First Online: 29 April 2025
Declarations
:
: All authors reported medical writing support for the manuscript from Bristol Myers Squibb. Yu-Mao Chen, Yue Zhong, Yu Chen Barrett, and Jing Zheng are employees of Bristol Myers Squibb and own stocks of Bristol Myers Squibb. Zhuang Tian, Xiaoyan Li, Liwen Li, Qing Zhang, Jian'an Wang, Yunqi Shi, Daoquan Peng, Ping Yang, Wei Ma, Fang Wang, Wei Jin, Xiang Cheng, and Shuyang Zhang confirm that they have no conflicts of interest to declare.
: This trial was conducted in accordance with the principles of the Declaration of Helsinki and Guideline for Good Clinical Practice. The protocol has been approved by institutional review boards/ethics committees at each site. All patients have provided written informed consent prior to entering study.
